Has the possible inclusion of nonradiographic axial spondyloarthritis been factored into the ABILITY-2 study? Comment on the article by Mease et al. [electronic resource]
- Arthritis & rheumatology (Hoboken, N.J.) Oct 2015
- 2793 p. digital
Publication Type: Letter; Comment
2326-5205
10.1002/art.39230 doi
Antibodies, Monoclonal, Humanized--therapeutic use Antirheumatic Agents--therapeutic use Female Humans Male Spondylarthritis--drug therapy